Rekdal Ø - Search Results

1

LTX-315 sequentially promotes lymphocyte-independent and lymphocyte-dependent antitumor effects.

Liao HW, Garris C, Pfirschke C, Rickelt S, Arlauckas S, Siwicki M, Kohler RH, Weissleder R, Sundvold-Gjerstad V, Sveinbjørnsson B, Rekdal Ø, Pittet MJ. Liao HW, et al. Among authors: rekdal o. Cell Stress. 2019 Oct 14;3(11):348-360. doi: 10.15698/cst2019.11.204. Cell Stress. 2019. PMID: 31799501 Free PMC article.

2

Evidence for a direct antitumor mechanism of action of bovine lactoferricin.

Eliassen LT, Berge G, Sveinbjørnsson B, Svendsen JS, Vorland LH, Rekdal Ø. Eliassen LT, et al. Among authors: rekdal o. Anticancer Res. 2002 Sep-Oct;22(5):2703-10. Anticancer Res. 2002. PMID: 12529985

3

The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo.

Eliassen LT, Berge G, Leknessund A, Wikman M, Lindin I, Løkke C, Ponthan F, Johnsen JI, Sveinbjørnsson B, Kogner P, Flaegstad T, Rekdal Ø. Eliassen LT, et al. Among authors: rekdal o. Int J Cancer. 2006 Aug 1;119(3):493-500. doi: 10.1002/ijc.21886. Int J Cancer. 2006. PMID: 16572423

4

Therapeutic vaccination against a murine lymphoma by intratumoral injection of a cationic anticancer peptide.

Berge G, Eliassen LT, Camilio KA, Bartnes K, Sveinbjørnsson B, Rekdal O. Berge G, et al. Among authors: rekdal o. Cancer Immunol Immunother. 2010 Aug;59(8):1285-94. doi: 10.1007/s00262-010-0857-6. Epub 2010 Apr 27. Cancer Immunol Immunother. 2010. PMID: 20422410 Free PMC article.

5

Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315.

Camilio KA, Berge G, Ravuri CS, Rekdal O, Sveinbjørnsson B. Camilio KA, et al. Among authors: rekdal o. Cancer Immunol Immunother. 2014 Jun;63(6):601-13. doi: 10.1007/s00262-014-1540-0. Epub 2014 Mar 28. Cancer Immunol Immunother. 2014. PMID: 24676901 Free PMC article.

6

LTX-315 (Oncopore™): A short synthetic anticancer peptide and novel immunotherapeutic agent.

Camilio KA, Rekdal O, Sveinbjörnsson B. Camilio KA, et al. Among authors: rekdal o. Oncoimmunology. 2014 Jun 25;3:e29181. doi: 10.4161/onci.29181. eCollection 2014. Oncoimmunology. 2014. PMID: 25083333 Free PMC article.

7

The oncolytic peptide LTX-315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells.

Eike LM, Yang N, Rekdal Ø, Sveinbjørnsson B. Eike LM, et al. Among authors: rekdal o. Oncotarget. 2015 Oct 27;6(33):34910-23. doi: 10.18632/oncotarget.5308. Oncotarget. 2015. PMID: 26472184 Free PMC article.

8

The Cytolytic Amphipathic β(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 Melanoma.

Eike LM, Mauseth B, Camilio KA, Rekdal Ø, Sveinbjørnsson B. Eike LM, et al. Among authors: rekdal o. PLoS One. 2016 Feb 16;11(2):e0148980. doi: 10.1371/journal.pone.0148980. eCollection 2016. PLoS One. 2016. PMID: 26881822 Free PMC article.

9

LTX-315: a first-in-class oncolytic peptide that reprograms the tumor microenvironment.

Sveinbjørnsson B, Camilio KA, Haug BE, Rekdal Ø. Sveinbjørnsson B, et al. Among authors: rekdal o. Future Med Chem. 2017 Aug;9(12):1339-1344. doi: 10.4155/fmc-2017-0088. Epub 2017 May 11. Future Med Chem. 2017. PMID: 28490192

10

Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model.

Nestvold J, Wang MY, Camilio KA, Zinöcker S, Tjelle TE, Lindberg A, Haug BE, Kvalheim G, Sveinbjørnsson B, Rekdal Ø. Nestvold J, et al. Among authors: rekdal o. Oncoimmunology. 2017 Jun 16;6(8):e1338236. doi: 10.1080/2162402X.2017.1338236. eCollection 2017. Oncoimmunology. 2017. PMID: 28920000 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters